|
FH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41330305633869E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53309998029982E-09 |
| Normal-vs-Stage2 |
1.173680E-04 |
| Normal-vs-Stage3 |
2.769800E-04 |
| Normal-vs-Stage4 |
2.483100E-03 |
| Stage1-vs-Stage2 |
5.787800E-01 |
| Stage1-vs-Stage3 |
6.243600E-01 |
| Stage1-vs-Stage4 |
8.356000E-02 |
| Stage2-vs-Stage3 |
9.394600E-01 |
| Stage2-vs-Stage4 |
2.862200E-01 |
| Stage3-vs-Stage4 |
3.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.63079599508387E-11 |
| Normal-vs-AfricanAmerican |
1.36289999996819E-06 |
| Normal-vs-Asian |
5.155900E-02 |
| Caucasian-vs-AfricanAmerican |
5.546400E-01 |
| Caucasian-vs-Asian |
4.083200E-01 |
| AfricanAmerican-vs-Asian |
3.545000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70089498041648E-11 |
| Normal-vs-Female |
1.69120000004241E-06 |
| Male-vs-Female |
4.628600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79783999999517E-05 |
| Normal-vs-Extreme_Weight |
2.77110001611902E-10 |
| Normal-vs-Obese |
4.1159999997209E-07 |
| Normal-vs-Extreme_Obese |
6.535000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.473000E-01 |
| Normal_Weight-vs-Obese |
8.199000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.961600E-02 |
| Extreme_Weight-vs-Obese |
9.645000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.202050E-01 |
| Obese-vs-Extreme_Obese |
7.117700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59725999999694E-05 |
| Normal-vs-Age(41-60Yrs) |
5.25669952011754E-10 |
| Normal-vs-Age(61-80Yrs) |
2.89000001707507E-09 |
| Normal-vs-Age(81-100Yrs) |
1.235770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.502100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.117640E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.160800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.461600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.300400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.075200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.08750050368201E-10 |
| Normal-VS-Type2 PRCC |
2.78819999999236E-06 |
| Normal-VS-KIRP CIMP |
1.63091762317435E-12 |
| Normal-VS-Unclassified PRCC |
2.08670003498668E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.366800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.09399999947968E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
3.339800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.68790000052577E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.541380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.14890000238555E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.69849999515282E-08 |
| Normal-vs-N1 |
5.68549999968582E-07 |
| Normal-vs-N2 |
1.06850000003433E-06 |
| N0-vs-N1 |
9.543800E-02 |
| N0-vs-N2 |
9.433600E-02 |
| N1-vs-N2 |
4.528800E-01 |
|
|
